Medicare Enrolled
Dr. Edwin Jacobs, M.D.
Hematology & Oncology · Burbank, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Jacobs from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jacobs?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Jacobs
Dr. Edwin Jacobs is a hematology & oncology specialist in Burbank, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Jacobs performed 30,495 Medicare services across 2,907 unique beneficiaries.
Between the years covered by Open Payments, Dr. Jacobs received a total of $4,201 from 39 pharmaceutical and/or device companies across 211 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Jacobs is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 19% volume in CA
$4,201 industry payments
Medicare Practice Summary
Medicare Utilization ↗30,495
Medicare services
Top 19% in CA for hematology & oncology
2,907
Unique beneficiaries
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,605 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
12,640 | $6 | $23 |
| Denosumab injection (Prolia/Xgeva) | 3,600 | $17 | $59 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,879 | $8 | $21 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
2,729 | $8 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,379 | $106 | $378 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
2,195 | $10 | $29 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
776 | $6 | $17 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
709 | $67 | $227 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
567 | $8 | $23 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
519 | $71 | $268 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
452 | $13 | $44 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
209 | $98 | $341 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
191 | $32 | $106 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
169 | $154 | $528 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
118 | $109 | $372 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 107 | $133 | $518 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
104 | $1 | $6 |
| New patient office visit, complex (60-74 min) | 55 | $174 | $645 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
52 | $84 | $310 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
45 | $140 | $497 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$4,201
Total received (2018-2024)
Avg $600/year across 7 years
Top 46% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
211
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,129 (98.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$72 (1.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$265
2023
$271
2022
$209
2021
$49
2020
$16
2019
$2,979
2018
$411
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Regeneron Healthcare Solutions, Inc.
$75
Novartis Pharmaceuticals Corporation
$47
Gilead Sciences, Inc.
$33
Daiichi Sankyo Inc.
$26
Merck Sharp & Dohme LLC
$24
GlaxoSmithKline, LLC.
$24
E.R. Squibb & Sons, L.L.C.
$19
Bayer Healthcare Pharmaceuticals Inc.
$18
Top 3 companies account for 58.5% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$398
Amgen Inc.
$344
Novartis Pharmaceuticals Corporation
$324
Takeda Pharmaceuticals U.S.A., Inc.
$301
Genentech USA, Inc.
$263
EISAI INC.
$197
Celgene Corporation
$171
E.R. Squibb & Sons, L.L.C.
$158
GENZYME CORPORATION
$147
Seagen Inc.
$143
Seattle Genetics, Inc.
$143
AstraZeneca Pharmaceuticals LP
$128
Janssen Biotech, Inc.
$125
Merck Sharp & Dohme Corporation
$123
Incyte Corporation
$122
Regeneron Healthcare Solutions, Inc.
$115
Boehringer Ingelheim Pharmaceuticals, Inc.
$114
Puma Biotechnology, Inc.
$110
Astellas Pharma US Inc
$70
Lilly USA, LLC
$68
Bayer HealthCare Pharmaceuticals Inc.
$68
Clovis Oncology, Inc.
$61
GlaxoSmithKline, LLC.
$57
Gilead Sciences, Inc.
$52
JAZZ PHARMACEUTICALS INC.
$43
AbbVie, Inc.
$41
Alexion Pharmaceuticals, Inc.
$40
ADC Therapeutics America, Inc.
$36
Janssen Pharmaceuticals, Inc
$35
C. R. Bard, Inc. & Subsidiaries
$28
Daiichi Sankyo Inc.
$26
EUSA Pharma (US) LLC
$26
Merck Sharp & Dohme LLC
$24
Octapharma USA, Inc.
$20
SANOFI-AVENTIS U.S. LLC
$18
Bayer Healthcare Pharmaceuticals Inc.
$18
Rigel Pharmaceuticals, Inc.
$17
MEDIVATION FIELD SOLUTIONS LLC
$14
Shionogi Inc
$13
Top 3 companies account for 25.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · Abraxane · Avastin · BAVENCIO · BOSULIF · Balversa · Bard Urinary Drainage Bag · Blincyto · CABLIVI · DARZALEX · ELITEK · ELOCTATE · Enhertu · Erleada · FASLODEX · GAUCHER-DISEASE · GILOTRIF · IBRANCE · IMFINZI · INLYTA · Inrebic · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MVASI · Mulpleta · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAGAM · OPDIVO · OPDUALAG · PIQRAY · PROMACTA · Perjeta · Prolia · Revlimid · Rubraca · SANDOSTATIN LAR · SOLIRIS · SUTENT · Stivarga · Sylvant · TASIGNA · TECENTRIQ · TUKYSA · Tavalisse · VERZENIO · VYXEOS · Vitrakvi · XALKORI · XARELTO · XOSPATA · XTANDI · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
371
Per 100K population
3.8
County median income
$87,760
Nearest hospital
PROVIDENCE SAINT JOSEPH MEDICAL CTR
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Jacobs is a mixed practice specialist, with above-average Medicare volume (top 19% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Jacobs experienced with epoetin alfa injection (procrit) for anemia?
Based on Medicare claims data, Dr. Jacobs performed 12,640 epoetin alfa injection (procrit) for anemia services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Jacobs receive payments from pharmaceutical companies?
Yes. Dr. Jacobs received a total of $4,201 from 39 companies across 211 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jacobs's costs compare to other hematology & oncology specialists in Burbank?
Dr. Jacobs's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jacobs) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Burbank
Browse hematology & oncology specialists in Burbank ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology